Kuchyne na miru

Editorial Podcasts

Oct 03, 2019
Pharmaceutical Executive
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in regard to receiving therapies, how to engage with patients more effectively, and where she sees the pharma industry in terms of patient engagement and patient centricity.
Oct 02, 2019
By Pharmaceutical Executive Editors
Sep 19, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his finance background, global pricing issues, and challenges and opportunities for EMEA biopharma breaking into the US market.
Sep 05, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with Pharm Exec editors about his journey from clinical work to creating biotech startups, which has included research, clinical work, and the launch of two startups.
Aug 22, 2019
Pharmaceutical Executive
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centricity fuels innovation, the difference between patient and customer centricity, and educational programs that need to be implemented for patients, providers, and payers.
Aug 08, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
Jul 25, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Pharm Exec editors share insights into what they've been working on this summer for the June, July, and August issues; plus a sneak peek into what's coming in September!
Jul 11, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.
Jun 21, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
Jun 11, 2019
Pharmaceutical Executive
By Christen Harm, Lisa Henderson
Pharm Exec editors speak with Jigar Raythatha, CEO of Constellation Pharmaceuticals. He talks about his roles, the importance of having a Plan B in biotech, creating a translationally enabled company, and how he leads his team at Constellation.
native1_300x100
www.cialis-viagra.com.ua/viagra-sildenafil/viagra-25-mg/

www.ry-diplomer.com

https://velotime.com.ua
lorem ipsum